 Veru stock collapsed Thursday after the FDAs advisors voted against the companys cancer drug turned Covid treatment. The post Veru Stock Plummets 65 After FDA Advisors Vote Down Cancer-Turned-Covid Drug appeared first on Investors Business Daily. 